Validation of preoperative variables and stratification of patients to help predict benefit of cytoreductive nephrectomy in the targeted therapy ERA

OBJECTIVES: To further elucidate which patients with metastatic renal cell carcinoma (mRCC) may benefit from cytoreductive nephrectomy (CN) before targeted therapy (TT), and to assess the overall survival of patients undergoing CN and TT versus TT alone. MATERIALS AND METHODS: We identified 88 patie...

Descripción completa

Detalles Bibliográficos
Autores principales: Manley, Brandon J., Kim, Eric H., Vetter, Joel M., Potretzke, Aaron M., Strope, Seth A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedade Brasileira de Urologia 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5462133/
https://www.ncbi.nlm.nih.gov/pubmed/28128914
http://dx.doi.org/10.1590/S1677-5538.IBJU.2015.0118

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5462133/
https://www.ncbi.nlm.nih.gov/pubmed/28128914
http://dx.doi.org/10.1590/S1677-5538.IBJU.2015.0118

Ejemplares similares